Absolute configuration of (+)-α-dihydrotetrabenazine, an active metabolite of tetrabenazine

Chirality

Volumn 9, Issue 1, 1997, Pages 59-62

  Kilbourn, Michael R ^a,c   Lee, Lihsueh C ^a   Heeg, Mary J ^b   Jewett, Douglas M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

chiral column chromatography; enzyme; resolution of enantiomers; X ray crystallography

Indexed keywords

BENZO[A]QUINOLIZINE DERIVATIVE; DIHYDROTETRABENAZINE; DRUG METABOLITE; TETRABENAZINE;

ARTICLE; CHIRAL CHROMATOGRAPHY; CHIRALITY; DRUG STRUCTURE; ENANTIOMER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MONOAMINE RELEASE; PRIORITY JOURNAL; X RAY CRYSTALLOGRAPHY;

ANTI-DYSKINESIA AGENTS; CHROMATOGRAPHY, LIQUID; CRYSTALLOGRAPHY, X-RAY; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; STEREOISOMERISM; TETRABENAZINE;

EID: 0030969697     PISSN: 08990042     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-636X(1997)9:1<59::AID-CHIR11>3.0.CO;2-P     Document Type: Article

References (12)

1. Pletscher, A., Brossi, A., Gey, K.F. Benzoquinoline derivatives: A new class of monoamine decreasing drugs with psychotropic action. Int. Rev. Neurobiol. 4:275-306, 1962.
2. Schwarz, D.E., Bruderer, H., Rieder, J. Brossi, A. Metabolic studies of tetrabenazine, a psychotropic drug in animals and man. Biochem. Pharmacol. 15:645-655, 1966.
3. Mehvar, R., Jamali, F. Concentration-effect relationships of tetrabenazine and dihydrotetrabenazine in the rat. J. Pharm. Sci. 76:461-465, 1987.
4. Henry, J.-P., Scherman, D. Radioligands of the vesicular monoamine transporter and their use as markers of monoamine storage vesicles. Biochem. Pharmacol. 38:2395-2404, 1989.
5. Kilbourn, M.R. PET radioligands for vesicular neurotransmitter transporters. Med. Chem. Res. 5:113-126, 1994.
6. Lee, L.C., Vander Borght, T., Sherman, P.S., Frey, K.A., Kilbourn, M.R. In vitro and in vivo structure-activity relationships of benzoisoquinoline ligands for the brain synaptic vesicle monoamine transporter. J. Med. Chem. 39:191-196, 1996.
7. Kilbourn, M., Lee, L., Vander Borght, T., Jewett, D., Frey, K. Binding of α-dihydrotetrabenazine to the vesicular monoamine transporter is stereospecific. Eur. J. Pharmacol. 278:249-252, 1995.
8. Sheldrick, G.M. SHELXL-93. University of Gottingen, Gottingen, Germany, 1993.
9. 11C]tetrabenazine, a vesicular monoamine uptake inhibitor, for PET imaging studies. Appl. Radiat. Isot. 44:673-676, 1993.
10. Rubiralta, M., Diez, A., Bosch, J., Feliz, M., Solans, X. NMR spectroscopy and X-ray crystallography of benzo[a]quinolizidines. Heterocycles 27:1653-1664, 1988.
11. 11C]dihydrotetrabenazine by dynamic PET: Measurement of the vesicular monoamine transporter. J Cerebral Blood Flow Metab. 1996 16:1288-1299, 1996.
12. Loubinoux, B., Coudert, G., and Guillaumet, G. Selective demethylation of aryl methyl ethers. Synthesis 638-640, 1983.